Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsIn 2022, Britannia Life Sciences Inc has already paid €0.0296 in dividends. The last payout was in July 2022.
Financials
In the last quarter, Britannia Life Sciences Inc had revenue of €62.52k and net profit of €739.03k
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 62.52k | 40.94% |
| Gross profit | 11.98k | 32.08% |
| Net profit | 739.03k | 271.53% |
| EBITDA | -211.28k | 49.23% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €6.7m |
Number of shares | 162.25m |
52-week high/low | €0.0699 - €0.0381 |
| Dividends | No |
Beta | -0.06 |
P/E ratio | 0.70 |
PEG ratio | 0.01 |
P/B ratio | 0.48 |
P/S ratio | 25.95 |
Company profile
Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is based in Toronto, Canada.
| Name | Britannia Life Sciences Inc |
| CEO | Peter James Shippen |
| Headquarters | Toronto,
on USA |
| Website | |
| IPO | 18/11/2021 |
| Employees | 28 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Cnq | BLAB.CN |
Frankfurt | L020.F |